Cinacalcet Coupons & Discount Card - Compare Prices Near You
generic Sensipar
My prescription
Edit
30MG, Cinacalcet (30 Tablets)
Select pharmacy
Rite Aid
$13.74
COUPON PRICE
Walgreens
$237.11
COUPON PRICECinacalcet savings card
Show this card to your pharmacistRite Aid
$13.74
BIN
ID
PCN
GRP
019876
LH5EBBAAD3
CHIPPO
LHX
Powered by
More prescriptions for hyperparathyroidism
More prescriptions for hyperparathyroidism
Cinacalcet dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 30MG | 30 Tablets | $13.24 | $0.44 |
| 60MG | 30 Tablets | $20 | $0.67 |
| 90MG | 30 Tablets | $31.04 | $1.03 |
Cinacalcet Side Effects
You might experience nausea, vomiting, or unusual tiredness while taking this medication. These are common side effects and typically mild, but if they persist or worsen, it's important to consult your healthcare provider. The medication is often beneficial despite these mild side effects, and many users do not experience significant issues.
However, Cinacalcet can lead to low calcium levels in your blood. Your healthcare provider will monitor your calcium levels, but be alert for symptoms such as numbness or tingling of the skin, severe muscle spasms, seizures, or a fast or irregular heartbeat. These require immediate medical attention.
Serious side effects can include black or bloody stools, stomach or abdominal pain, and vomit that contains blood or resembles coffee grounds. Seek prompt medical care if you notice these symptoms. Allergic reactions to this drug are rare but can be serious. Watch for signs like rash, itching, swelling (particularly of the face, tongue, or throat), severe dizziness, or difficulty breathing, and seek emergency help if they occur.
This summary does not cover all possible side effects. If you encounter any symptoms not mentioned here, please contact your healthcare provider for guidance.
Interactions
What is the best medication for hyperparathyroidism?
The best medication for hyperparathyroidism depends on the underlying cause and the patient's specific condition. For primary hyperparathyroidism, surgery to remove the overactive parathyroid gland is often the most effective treatment. However, if surgery is not an option, medications such as cinacalcet may be used to help control calcium levels. In secondary hyperparathyroidism, often related to chronic kidney disease, treatments may include vitamin D analogs and phosphate binders. It is important for the patient to consult with a healthcare provider to determine the most appropriate treatment plan.
What is the goal of cinacalcet?
The goal of cinacalcet is to lower levels of parathyroid hormone (PTH), calcium, and phosphorus in the body. It is commonly used to treat conditions such as secondary hyperparathyroidism in patients with chronic kidney disease on dialysis, and hypercalcemia in patients with parathyroid carcinoma or primary hyperparathyroidism when surgery is not an option.
Why do dialysis patients take cinacalcet?
Dialysis patients often take cinacalcet to manage secondary hyperparathyroidism, a condition common in individuals with chronic kidney disease. This medication helps lower parathyroid hormone levels, calcium, and phosphorus in the blood, which can help prevent bone disease and other complications associated with kidney failure.
What is the role of cinacalcet in hyperparathyroidism?
Cinacalcet is used to treat secondary hyperparathyroidism in patients with chronic kidney disease on dialysis, as well as hypercalcemia in patients with parathyroid carcinoma. It works by increasing the sensitivity of the calcium-sensing receptors on the parathyroid gland, which helps to lower parathyroid hormone (PTH) levels, calcium, and phosphorus levels in the blood. This can help manage the complications associated with these conditions.
Does cinacalcet affect bone density?
Cinacalcet primarily works by lowering parathyroid hormone (PTH) levels, which can have an indirect effect on bone metabolism. By reducing PTH, cinacalcet may help in managing bone turnover and potentially improve bone density in patients with conditions like secondary hyperparathyroidism. However, the direct impact on bone density can vary, and it is important for patients to discuss their specific situation with their healthcare provider.